vitamin k 3 has been researched along with Disease Exacerbation in 2 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using a mouse model of prostate cancer, the combination of α-TOS, VK3 and AA was more efficient in tumor suppression than when the drugs were given separately, without deleterious side effects." | 1.38 | Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death. ( Alleva, R; Borghi, B; Dong, L; Garrone, B; Goodwin, J; Guerrieri, R; Manzella, N; Milanese, C; Neuzil, J; Nguyen, M; Nocchi, L; Santarelli, L; Staffolani, S; Tomasetti, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osada, S | 1 |
| Yoshida, K | 1 |
| Tomasetti, M | 1 |
| Nocchi, L | 1 |
| Neuzil, J | 1 |
| Goodwin, J | 1 |
| Nguyen, M | 1 |
| Dong, L | 1 |
| Manzella, N | 1 |
| Staffolani, S | 1 |
| Milanese, C | 1 |
| Garrone, B | 1 |
| Alleva, R | 1 |
| Borghi, B | 1 |
| Santarelli, L | 1 |
| Guerrieri, R | 1 |
1 review available for vitamin k 3 and Disease Exacerbation
| Article | Year |
|---|---|
A novel strategy for advanced pancreatic cancer - progression of molecular targeting therapy.
Topics: Cell Division; Disease Progression; Drug Delivery Systems; Humans; Pancreatic Neoplasms; Phosphoryla | 2009 |
1 other study available for vitamin k 3 and Disease Exacerbation
| Article | Year |
|---|---|
Alpha-tocopheryl succinate inhibits autophagic survival of prostate cancer cells induced by vitamin K3 and ascorbate to trigger cell death.
Topics: Animals; Apoptosis Inducing Factor; Ascorbic Acid; Autophagy; Caspases; Cell Line, Tumor; Disease Pr | 2012 |